Literature DB >> 21556835

The use of continuous glucose monitoring in the practical management of glycogen storage disorders.

Fiona J White1, Simon A Jones.   

Abstract

Continuous glucose monitoring systems (CGMS) are now in widespread use in diabetes management with an increasing evidence base. There are few reports of their use in GSD. Liver glycogen storage disorders (GSDs) are most often managed by intensive dietary regimens. Risks of over and under-treatment remain. We describe our use of CGMS in a cohort of GSD patients, the results obtained and the frequency of complications. Our experience is that CGM is a reliable, well accepted and valid tool in the monitoring of GSD patients and allows for assessment of blood sugar control in the 'real-life' setting, unlike hospital admissions. Combining CGM with urine ketone and / or blood lactate measurements, again at home, improves the investigation yet further. It is possible to perform CGM for periods including both schooldays and weekends, and also to change the dietary regimen during the period of monitoring to reduce the frequency of assessments. Risks of decreased reliability in the low range of blood sugars may be outweighed by the increased validity of the patient being in the home environment, with a normal diet and activity schedule.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21556835     DOI: 10.1007/s10545-011-9335-3

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  7 in total

1.  Clinical evaluation of a portable lactate meter in type I glycogen storage disease.

Authors:  A C Saunders; H A Feldman; C E Correia; D A Weinstein
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  A review of current evidence with continuous glucose monitoring in patients with diabetes.

Authors:  Christophe De Block; Begoña Manuel-y-Keenoy; Luc Van Gaal
Journal:  J Diabetes Sci Technol       Date:  2008-07

3.  Continuous glucose monitoring in children with glycogen storage disease type I.

Authors:  E Hershkovitz; A Rachmel; H Ben-Zaken; M Phillip
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

4.  Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

Authors:  Richard M Bergenstal; William V Tamborlane; Andrew Ahmann; John B Buse; George Dailey; Stephen N Davis; Carol Joyce; Tim Peoples; Bruce A Perkins; John B Welsh; Steven M Willi; Michael A Wood
Journal:  N Engl J Med       Date:  2010-06-29       Impact factor: 91.245

Review 5.  Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I).

Authors:  Jan Peter Rake; Gepke Visser; Philippe Labrune; James V Leonard; Kurt Ullrich; G Peter A Smit
Journal:  Eur J Pediatr       Date:  2002-08-24       Impact factor: 3.183

Review 6.  Consensus guidelines for management of glycogen storage disease type 1b - European Study on Glycogen Storage Disease Type 1.

Authors:  Gepke Visser; Jan Peter Rake; Philippe Labrune; James V Leonard; Shimon Moses; Kurt Ullrich; Udo Wendel; G Peter A Smit
Journal:  Eur J Pediatr       Date:  2002-09-13       Impact factor: 3.183

7.  Continuous glucose monitoring in conditions other than diabetes.

Authors:  Alberto Maran; Cristina Crepaldi; Angelo Avogaro; Susanna Catuogno; Alberto Burlina; Alessandro Poscia; Antonio Tiengo
Journal:  Diabetes Metab Res Rev       Date:  2004 Nov-Dec       Impact factor: 4.876

  7 in total
  10 in total

1.  Alternative nighttime nutrition regimens in glycogen storage disease type I: a controlled crossover study.

Authors:  Michel Hochuli; Emanuel Christ; Fabian Meienberg; Roger Lehmann; Jan Krützfeldt; Matthias R Baumgartner
Journal:  J Inherit Metab Dis       Date:  2015-06-25       Impact factor: 4.982

2.  Role of continuous glucose monitoring in the management of glycogen storage disorders.

Authors:  Mrudu Herbert; Surekha Pendyal; Mugdha Rairikar; Carine Halaby; Robert W Benjamin; Priya S Kishnani
Journal:  J Inherit Metab Dis       Date:  2018-05-25       Impact factor: 4.982

3.  Continuous glucose monitoring in children with glycogen storage disease type I.

Authors:  Ç S Kasapkara; G Cinasal Demir; A Hasanoğlu; L Tümer
Journal:  Eur J Clin Nutr       Date:  2013-10-23       Impact factor: 4.016

Review 4.  Continuous glucose monitoring: current use and future directions.

Authors:  Daniel DeSalvo; Bruce Buckingham
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

Review 5.  Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring of dietary management and future directions.

Authors:  Terry G J Derks; Margreet van Rijn
Journal:  J Inherit Metab Dis       Date:  2015-01-30       Impact factor: 4.982

Review 6.  Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs.

Authors:  Terry G J Derks; David F Rodriguez-Buritica; Ayesha Ahmad; Foekje de Boer; María L Couce; Sarah C Grünert; Philippe Labrune; Nerea López Maldonado; Carolina Fischinger Moura de Souza; Rebecca Riba-Wolman; Alessandro Rossi; Heather Saavedra; Rupal Naik Gupta; Vassili Valayannopoulos; John Mitchell
Journal:  Nutrients       Date:  2021-10-27       Impact factor: 5.717

7.  A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets.

Authors:  Alessandro Rossi; Annieke Venema; Petra Haarsma; Lude Feldbrugge; Rob Burghard; David Rodriguez-Buritica; Giancarlo Parenti; Maaike H Oosterveer; Terry G J Derks
Journal:  J Clin Endocrinol Metab       Date:  2022-08-18       Impact factor: 6.134

Review 8.  Dynamic Methods for Childhood Hypoglycemia Phenotyping: A Narrative Review.

Authors:  Alessandro Rossi; Martijn G S Rutten; Theo H van Dijk; Barbara M Bakker; Dirk-Jan Reijngoud; Maaike H Oosterveer; Terry G J Derks
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-17       Impact factor: 6.055

9.  A preliminary study of telemedicine for patients with hepatic glycogen storage disease and their healthcare providers: from bedside to home site monitoring.

Authors:  Irene J Hoogeveen; Fabian Peeks; Foekje de Boer; Charlotte M A Lubout; Tom J de Koning; Sebastiaan Te Boekhorst; Robert-Jan Zandvoort; Rob Burghard; Francjan J van Spronsen; Terry G J Derks
Journal:  J Inherit Metab Dis       Date:  2018-03-29       Impact factor: 4.982

10.  A retrospective in-depth analysis of continuous glucose monitoring datasets for patients with hepatic glycogen storage disease: Recommended outcome parameters for glucose management.

Authors:  Fabian Peeks; Irene J Hoogeveen; R Lude Feldbrugge; Rob Burghard; Foekje de Boer; Marieke J Fokkert-Wilts; Melanie M van der Klauw; Maaike H Oosterveer; Terry G J Derks
Journal:  J Inherit Metab Dis       Date:  2021-05-05       Impact factor: 4.982

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.